Clinical Case Conference 1. James L. Levenson, M.D., and Robert K. Schneider, M.D., on Boundary Issues and the Challenge of the Somatizing Patient (Open to APA members only.)
Debate: Resolved: The RRC Should Continue to Require That Psychiatric Residency Programs Must Demonstrate That the Residents Have Achieved Competency in Psychodynamic Psychotherapy Moderator: Sheila Judge, M.D.; Affirmative: Allan Tasman, M.D., Lisa A. Mellman, M.D.; Negative: Joel Yager, M.D., Eugene H. Rubin, M.D.
1. Jonathan M. Meyer, M.D., on Medical Care for the Chronically Mentally Ill: The Role of the Psychiatrist (Meet the Authors)
2. Robert Michels, M.D., on Who Should Be Psychoanalyzed?
3. Robert R. Conley, M.D., on What Is the Best Medication for People Suffering From Schizophrenia?
4. Larry E. Tune, M.D., on Dementia and Delirium
Focus Live Session 1. Presenters: Paul S. Appelbaum, M.D., and Laura W. Roberts, M.D., on Forensic and Ethical Issues in Psychiatry
L2. Signal Integration in the Brain Paul Greengard, Ph.D., Collaborative Session With the National Institute on Drug Abuse, Frontiers of Science Lecture Series
L3. The Changing Face of Mental Health Services David Mechanic, Ph.D., APA’s Benjamin Rush Award Lecture
L4. Psychiatry and Spirituality: A Holistic Perspective Sri Sri Ravi Shankar, International Psychiatrist Lecture Series
Master Educator Clinical Consultations
1. John C. Racy, M.D., on Treating One’s Students and Colleagues: The Eternal Challenge of Boundaries (Open to APA members only.)
2. Eugene V. Beresin, M.D., on Evaluation and Treatment of Eating Disorders (Open to APA members only.)
New Research Young Investigators’ Poster Session 1
CW1. How to Teach and Learn Cultural Competence in Geriatric Psychiatry APA Committee on Ethnic Minority Elderly; Chairperson: Iqbal Ahmed, M.D.
CW2. Can’t Work, Shouldn’t Work, Mustn’t Work: Assessing Function and Mental Impairment in Psychiatric Illness APA Corresponding Committee on Psychiatry in the Workplace; Chairperson: Marcia A. Scott, M.D.
CW3. Public Health and Mental Health Partnership in Terrorism and Disasters APA Committee on Psychiatric Dimensions of Disaster; Chairperson: Robert J. Ursano, M.D.
CW4. Child Soldiers: Child Victims of War and Terrorism: Psychosocial and Spiritual Needs APA Alliance; Co-Chairpersons: Mohammad Shafii, M.D., Rosalind Hayes, B.A.
CW5. Career Choices in Psychiatry: Exploring Fellowship Training APA Assembly Committee of Area Member-in-Training Representatives; Chairperson: Thor J. Cornelius, M.D.
CW6. Facilitating Research on Minority Populations by Minority Researchers APA Assembly Committee of Representatives of Minority/Underrepresented Groups; Chairperson: Jagannathan Srinivasaraghavan, M.D.
CW7. State Hospital Psychiatry: Been Down So Long It Looks Like Up to Me APA Caucus of State Hospital Psychiatrists and American Association of Psychiatric Administrators; Co-Chairpersons: Yad M. Jabbarpour, M.D., Beatrice M. Kovasznay, M.D.
CW8. Leadership Skills for Public Advocacy APA Committee on Public Affairs; Chairperson: Mary H. Davis, M.D.
CW9. Mission Possible: The Science of Psychiatry and the Art of Advocacy APA Committee on Developmental Disabilities; Chairperson: Donald J. Mordecai, M.D.
CW10. Bridging Across Culture and Generations: An Asian-American Perspective APA Committee of Asian-American Psychiatrists; Chairperson: Eric C. Li, M.D.
CW11. VA Mental Health’s Response to Terrorism APA Caucus of VA Psychiatrists; Co-Chairpersons: Albert C. Gaw, M.D., Patricia I. Ordorica, M.D.
IW1. Disruptive Employees: Feedback-Assisted Counseling and Treatment Co-Chairpersons: Eva C. Ritvo, M.D., Gonzalo F. Quesada, M.D.
IW2. The Office of the Future: Technology in Psychiatry American Association for Technology in Psychiatry Co-Chairpersons: Robert C. Hsiung, M.D., Ronnie S. Stangler, M.D.
IW3. E, K, and GHB: The New ABCs of Substance Abuse Collaborative Session With the National Institute on Drug Abuse; Chairperson: Richard N. Rosenthal, M.D.
IW4. Functional Imaging in Court: Uses and Controversies Chairperson: Daniel G. Amen, M.D.
IW5. Reinventing Careers: Transitions and Later-Life Strategies for Psychiatrists Chairperson: Carolyn B. Robinowitz, M.D.
IW6. Drug Abuse and Suicidal Behavior Collaborative Session With the National Institute on Drug Abuse; Chairperson: Eric D. Caine, M.D.
IW7. The Benzodiazepine Controversy Revisited Chairperson: Christopher K. Chung, M.D.
IW8. Are There Limits to Boundary Limits? Chairperson: Malkah T. Notman, M.D.
IW9. Brooklyn Mental Health Court: Felony Offenders With Mental Illness Co-Chairpersons: Nancy J. Needell, M.D., Carol Fisler, J.D.
IW10. Can Early Intervention Prevent Psychosis? Management of the Prodromal Phase Chairperson: Clarice J. Kestenbaum, M.D.
IW11. Detoxification of the Opioid-Dependent Chronic-Pain Patient Chairperson: Jon M. Streltzer, M.D.
IW12. Death by Suicide: The Words of Those Left Behind Chairperson: Michael F. Myers, M.D.
IW13. The After-Death Telephone Call to Family Members: Clinical Perspectives Co-Chairpersons: Sheila M. Loboprabhu, M.D., James W. Lomax II, M.D.
IW14. Early Trauma, PTSD, and HIV: Association With Transmission and Nonadherence Co-Chairpersons: Mary Ann Cohen, M.D.,Jack M. Gorman, M.D.
IW15. Responding to the Impact of Suicide on Clinicians Chairperson: Eric M. Plakun, M.D.
IW16. Cocaine and Tobacco Use During Pregnancy: Adverse Outcomes in Offspring Collaborative Session With the National Institute on Drug Abuse; Chairperson: Vincent L. Smeriglio, Ph.D.
IW17. Controversies at the Interface Between Religion and Psychiatric Practice Co-Chairpersons: Allan M. Josephson, M.D., John R. Peteet, M.D.
IW18. Psychiatric Research Perspectives in Latin America Co-Chairpersons: Rodrigo A. Muñoz, M.D., Pedro Ruiz, M.D.
5. Gregory E. Gray, M.D., on Evidence-Based Psychiatry (Meet the Authors)
6. Paul R. McHugh, M.D., on The Future Structure of Psychiatric Classification and Its Role in Enhancing Therapy, Teaching, and Research
7. Eric R. Marcus, M.D., on Untying the Gordian Knot: Comorbid Bipolar II Illness and Personality Disorders
8. Constantine Lyketsos, M.D., on Depression in Alzheimer’s and Other Neurologic Conditions: Evaluation and Treatment
9. Glenn J. Treisman, M.D., on HIV (for residents only)
Focus Live Session 2. Presenter: Jonathan R.T. Davidson, M.D., on PTSD and Anxiety Disorders: Test Your Knowledge
L5. Surviving Jock Culture Robert Lipsyte
L6. The Search for Genes of Bipolar Disorder: From Classical Genetics to Novel Molecular Targets Julien Mendlewicz, M.D., International Psychiatrist Lecture Series
L7. Mind, Brain, and Personality Disorders Glen O. Gabbard, M.D., APA’s Adolf Meyer Award Lecture
Master Educator Clinical Consultations
3. Robert G. Robinson, M.D., on Neuropsychiatry of Stroke: Recent Advances (Open to APA members only.)
4. Elizabeth Auchincloss, M.D., on Finding the Hidden Self: Engaging Difficult Patients in Exploratory Psychotherapy (Open to APA members only.)
Medical Update 1. Susan Lucak, M.D., on Irritable Bowel Syndrome
Research Consultation 1. David V. Sheehan, M.D., on Evaluating Evidence in Clinical Trials and Research Papers
Scientific and Clinical Report Sessions
Session 1. Issues in Schizophrenia
2. Rivastigmine and Glantamine Treatment of Schizophrenic Cognitive Impairment Mohammad Z. Hussain, M.D.
3. Dosing of Second-Generation Antipsychotics in a Large State Hospital System Leslie L. Citrome, M.D.
4. The Meaning of Response in Acute Schizophrenia Mary Anne Pressman, M.D.
Session 2. Anxiety Disorders
5. Carbon Dioxide Test in Respiratory Panic Disorder: A Clonazepam Trial Antonio E. Nardi, M.D.
6. Child Abuse and the Development of PTSD in a Canadian Epidemiological Sample Michael A. Van Ameringen, M.D.
7. Tiagabine Treatment of Social Anxiety Disorder Laszlo A. Papp, M.D.
Session 3. Spectrum of Personality Disorders
8. Childhood Prevalence of BPD Mary C. Zanarini, Ed.D.
9. Apparent Versus Reported Sadness: Correlation With Personality Traits Anand Pandya, M.D.
10. High-Lethality Suicide Attempts in BPD Supported by the National Institute of Mental Health; Paul H. Soloff, M.D.
Session 4. Recovery Issues With Schizophrenia
11. Do Patients With Schizophrenia Show Periods of Complete Recovery? A 20-Year Follow-Up Martin Harrow, Ph.D.
12. Twenty-Year Outcome in Schizophrenia: What’s Sex Got to Do With It? Linda S. Grossman, Ph.D.
13. Recovery From Schizophrenic Psychoses Until Age 35 Erika Lauronen
Session 5. Complications With Atypical Antipsychotics
14. A Program for Treating Weight Gain Induced by Atypical Antipsychotics Yael Nehama, M.D.
15. Increased Lipid Levels and Antipsychotic Medication Hannu J. Koponen, M.D.
16. QTc Prolongation Associated With Ziprasidone John W. Goethe, M.D.
Session 6. Psychotherapy and Psychopharmacology: Dissolving the Mind-Brain Barrier
17. Interpersonal Psychotherapy for Depressed Elders With Cognitive Dysfunction Mark D. Miller, M.D.
18. Integrating Psychotherapy With Medication to Improve Outcome Ira D. Glick, M.D.
19. Review of Psychotherapy Research Involving a Pill-Placebo Control Arthur Rifkin, M.D.
Session 7. Treatment of Depression
20. Duloxetine Versus Placebo in the Prevention of Relapse of MDD Michael J. Detke, M.D.
21. Response to Antidepressants Is Independent of Gender Tamar D. Wohlfarth, Ph.D.
22. Depression and BPD During the Immediate Prepartum Period Gisele Apter-Danon, M.D.
Session 8. Health Services
23. Treatment Effectiveness and Functional Recovery in Schizophrenia Supported by AstraZeneca Pharmaceuticals, Henry A. Nasrallah, M.D.
24. Ethnic-Matched, Culturally Competent, Model-Based ACT Team: Early Outcome Report Samuel F. Law, M.D.
25. Work Disability and Treatment Access in Psychiatry Farifteh F. Duffy, Ph.D.
CW12. Whither Our Own History? Debating the Value of the Study of Psychiatry’s Past APA Corresponding Committee on History and Library; Chairperson: Avram H. Mack, M.D.
CW13. What’s New in Psychiatry and the Law at APA? APA Council on Psychiatry and Law and APA Committee on Judicial Action; Chairperson: Renée L. Binder, M.D.
CW14. Novel Careers in Psychiatry: Women Who Have Made Their Own WayAPA Committee on Women; Co-Chairpersons: Melva I. Green, M.D., Madelaine M. Wohlreich, M.D.
CW15. Update on Practice Guidelines: PTSD and Acute Stress Disorder APA Steering Committee on Practice Guidelines; Chairperson: John S. McIntyre, M.D.
CW16. Public Psychiatry: Leading the Way in Transforming Service Delivery in the 21st Century APA Council on Social Issues and Public Psychiatry; Co-Chairpersons: Altha J. Stewart, M.D., Jeffrey L. Geller, M.D.
CW17. Fitness to Practice Medicine: The Roles of the Evaluating Psychiatrist APA Corresponding Committee on Physician Health, Illness, and Impairment; Chairperson: John A. Fromson, M.D.
CW18. Terror at Home: Addressing Domestic Violence in Your Practice APA Committee on Family Violence and Abuse; Chairperson: Carole L. Warshaw, M.D.
CW19. Approaches to Assessment and Diagnosis of Infants and Small Children APA Council on Children, Adolescents, and Their Families; Chairperson: William C. Wood, M.D.
CW20. Helping Older Persons With Schizophrenia: Treatment, Research, and Policy APA Council on Aging; Chairperson: Carl I. Cohen, M.D.
IW19. Psychiatry in the Primary Care Setting: Making It Work for the Psychiatrist Chairperson: John C. Urbaitis, M.D.
IW20. No-Suicide Decisions, Contracts, and Assessment of Risk: Values and Cautions Chairperson: Robert C. Drye, M.D.
IW21. Chronic Fatigue Syndrome: Disease or Abnormal Illness Behavior? Chairperson: Peter Manu, M.D.
IW22. Career Development for Minority Women Psychiatrists Chairperson: Surinder S. Nand, M.D.
IW23. What Psychiatry Residents Can Expect From NIMH-Sponsored Research Training Co-Chairpersons: Joseph R. Calabrese, M.D., Della M. Hann, Ph.D.
IW24. Treating Physicians: Issues in Diversity Chairperson: Michael F. Myers, M.D.
IW25. Drug Abuse and Mental Health Treatment in Lieu of Imprisonment Chairperson: Rodrigo A. Muñoz, M.D.
IW26. Obtaining Research Funding From NIH: Keys to Successful Grant Writing Collaborative Session With the National Institute on Drug Abuse; Chairperson: Lucinda L. Miner, Ph.D.
IW27. To Smoke or Not to Smoke: The Dilemmas of Tobacco-Free Addiction Treatments Collaborative Session With the National Institute on Drug Abuse; Co-Chairpersons: Petros Levounis, M.D., Edward V. Nunes, M.D.
IW28. The Transitional Object in Dementia Co-Chairpersons: Sheila M. Loboprabhu, M.D., James W. Lomax II, M.D.
IW29. Boundary Violation: History, Typology, and Prevention Chairperson: Albert C. Gaw, M.D.
IW30. Cognitive Therapy and Pharmacotherapy: Teaching Residents Integrated Treatment Methods Chairperson: Donna M. Sudak, M.D.
IW31. Treating African-American Patients With Psychotherapy: A Training Dilemma Co-Chairpersons: Anu A. Matorin, M.D., Henry L. McCurtis, M.D.
IW32. Risk-Management Issues in Psychiatric Practice Psychiatrists’ Purchasing Group Inc., Chairperson: Alan I. Levenson, M.D.
Presidential Symposium 1. The Biopsychosocial Model: Myth or Reality? Chairperson: J. Pierre Loebel, M.D.; Co-Chairperson: Marcia Kraft Goin, M.D.
S1. Brain Stimulation: New Treatments for Mood Disorders
A. ECT: Role in Brain Stimulation Harold A. Sackeim, Ph.D.
B. Magnetic Seizure Therapy: Development of a Novel Convulsive Treatment Sarah H. Lisanby, M.D.
C. Repeated Prefrontal Repetitive Transcranial Magnetic Stimulation as an Antidepressant: An Update Mark S. George, M.D.
D. The Use of Vagus Nerve Stimulation (VNS) in the Long-Term Treatment of Mood Disorders Lauren B. Marangell, M.D.
S2. Treatment of Maladaptive Personality Traits
A. Drug Treatment of Maladaptive Personality Traits James H. Reich, M.D.
B. Neurobiology, Comorbidity, and Drug Treatment of Childhood-Abused BPD Patients Thomas Rinne, M.D.
C. Development and Treatment of Family Pathology Around Cluster-B Traits David M. Allen, M.D.
D. Cognitive Therapy for Maladaptive Personality Traits David P. Bernstein, Ph.D.
E. Affective Deficits in Recurrent Suicidal Behavior Paul S. Links, M.D.
F. Narcissistic Traits in Substance Abusers: Any Treatment Implications? Per Vaglum, M.D.
S3. Functional Brain Imaging of Addiction Collaborative Session With the National Institute on Drug Abuse
A. Neuropsychiatric Implications of Mapping Reward/Aversion Circuitry Hans C. Breiter, M.D.
B. Endogenous Opioid Neurotransmissions: Interfacing Reward and Stress Regulation Jon-Kar Zubieta, M.D.
C. Chronic Effects of Drug Use and HIV Linda Chang, M.D.
D. Neurobiological Substrates of Stimulant Action and Reward Elliot A. Stein, Ph.D.
S4. Treatment of Chronic Pain in Recovering Addicts Collaborative Session With the National Institute on Drug Abuse
A. Pain Assessment and Issues in Screening Russ Portenoy, M.D.
B. Assessing Aberrant Drug-Taking Behaviors in Medically Ill Patients With Pain Steve Passik, Ph.D.
C. The Development and Treatment of Opioid-Induced Hyperalgesia Walter Ling, M.D.
D. Prescribing Pain Medications for Recovering Addicts With Chronic Pain Richard Brown, M.D.
E. Principles of Pain Treatment in Addictive Disorders Seddon R. Savage, M.D.
S5. Child Soldiers, Child and Adolescent Victims of War and Terrorism: Biopsychosocial Treatment for Reintegration Into Family and Society APA Alliance
A. Children’s Response to Terrorism in Nairobi: The 1998 U.S. Embassy Bombing in Kenya Frank G. Njenga, M.D.
B. The Voices of Girl-Child Soldiers Yvonne Keairns, Ph.D.
C. Terror and Terrorism: Community Responses and Needs Robert J. Ursano, M.D.
D. Child Soldiers Reintegration: A Holistic, Community-Based Approach Michael Wessells, Ph.D.
E. Survey of Youth, Violence, and Public Health in Bogota, Colombia Luis Duque, M.D.
S6. New Directions in Terrorism and Political Violence: Causes and Responses International Society for Political Psychology and APA Council on Global Psychiatry
A. Path to Collective Madness Dipak Gupta, Ph.D.
B. When Hatred Is Bred in the Bone Jerrold M. Post, M.D.
C. Terror on the Internet: The New Arena, The New Challenges Gabriel Weimann, Ph.D.
D. Cultural Approaches Linking Terrorism and Traumas Stevan M. Weine, M.D.
E. Resource Loss and Impact on Civilian Populations: Individuals and System Outcomes Stevan Hobfoll, Ph.D.
S7. I Rest My Case American Association of Practicing Psychiatrists
A. The HIPAA Suit Robert L. Pyles, M.D.
B. Shrager Versus Magellan Daniel Shrager, M.D.
C. The RICO Suit Janis G. Chester, M.D.
D. Eist Versus Maryland BPQA Harold I. Eist, M.D.
S8. From Response to Recovery: The Consumer and Clinician Collaboration in Depression and Psychosis
A. Sarah’s Struggle: Adolescence, Abandonment, and Bipolar Disorder Sarah Duckworth
B. To Be or Not To Be? The Hidden Crisis of Adult and Adolescent Male Depression and Suicide William S. Pollack, Ph.D.
C. From Illness to Wellness: New Strategies for Recovery Anne Whitman, Ph.D.
D. Bipolar Disorder and MDD in Mid-Life Paul E. Keck Jr., M.D.
E. Geriatric Depression, Alcohol Abuse, and Suicidality Everet Page
F. Late-Life Depression: Is Getting Well Enough? Sumer Verma, M.D.
S9. Recent Advances in the Treatment of Psychiatric Disorders in Primary Care: A U.S./U.K. Perspective
A. The Pathways Study: A Randomized Trial of Collaborative Care in Patients With Diabetes and Depression Wayne J. Katon, M.D.
B. Cognitive-Behavior Therapy and Medication for Primary Care Panic Disorder: Sustained Superiority to Usual Care Peter P. Roy-Byrne, M.D.
C. Problem-Solving Treatment by Nurses for Psychological Disorders in Primary Care Lawrence Mynors-Wallis, D.M.
D. Cost-Effectiveness of Antidepressants in Primary Care Robert C. Peveler, M.D.
S10. Mental Health Teams: Health Promotion and Preservation in War and Peace
A. Mental Health Teams: Background and Recent History James J. Staudenmeier Jr., M.D.
B. Psychology of War Jason L. Engeriser, M.D.
C. Recent Mental Health Team Efforts in the Combat-Support Hospital Robert D. Forsten, M.D.
D. Mental Health Intervention in Mortuary Affairs Workers During Combat Panakkal David, M.D.
E. Health-Promotion and Preventive-Medicine Efforts in the Most Recent Gulf Wars Robert T. Ruiz, M.D.
F. Jealous in Honor, Sudden in Quarrel: Psychiatric Practice in Operation Iraqi Freedom William F. Haning III, M.D.
G. Emotional Cycle of Deployment: Family and Military-Member Perspective Simon H. Pincus, M.D.
S11. PTSD in Persons With Serious Mental Illness
A. Prevalence and Patterns of PTSD Among Persons With Severe Mental Illness David B. Albert, Ph.D.
B. An Exploration of PTSD and MDD Comorbidity Patricia Resnick, Ph.D.
C. Assessment and Treatment of Trauma in Persons With Serious Mental Illness Kristina H. Muenzenmaier, M.D.
D. Cognitive-Behavioral Treatment of PTSD in Clients With Severe Mental Illness Kim T. Mueser, Ph.D.
S12. Behavioral Dimensions of Psychiatric Disorders
A. Impulsivity in Psychiatric Disorders Alan C. Swann, M.D.
B. Aggression in Personality Disorders Emil F. Coccaro, M.D.
C. Mood Reactivity Dimension in Diagnosis Conrad M. Swartz, M.D.
D. The Dimensional Construct in Psychiatric Disorders Stephen B. Shanfield, M.D.
S13. Neurodevelopment and Schizophrenia: Clinical and Basic Science Perspectives
A. In-Utero Exposure to Infection and Schizophrenia in Adult Offspring Alan S. Brown, M.D.
B. Prenatal Viral Infection, Brain Development, and Schizophrenia S. Hossein Fatemi, M.D.
C. Advanced Paternal Age and Risk for Schizophrenia Dolores Malaspina, M.D.
D. Early Gestational Irradiation in the Primate as a Model of Schizophrenia Lynn D. Selemon, Ph.D.
S14. Current Concepts of the Neurobiology of the Self
A. What Neuropathology Can Teach Us About the Neurobiology of the Self Todd E. Feinberg, M.D.
B. Neuroimaging the Self Julian P. Keenan, Ph.D.
C. Self, Memory, and the Brain Joseph LeDoux, Ph.D.
D. Affect Regulation, the Right Hemisphere, and the Self Allan N. Schore, Ph.D.
S15. The Development of ADAP: The Adolescent Depression Awareness Program
A. Current Status of Depression Education in Schools Boglarka Szabo, M.D.
B. Development of a Model Depression Education Curriculum Karen L. Swartz, M.D.
C. Creation of Supplemental Learning Tools for Depression Education Sallie Mink, B.S.N.
D. Evaluation of the ADAP Teenage Depression Curriculum Todd S. Cox, M.D.
E. Change in Adolescent Attitudes About Depression Treatment Elizabeth A. Kastelic, M.D.
F. Training of ADAP Educators: Bringing the Curriculum to Schools Sally G. Hess, B.S.N.
S16. The Death Penalty: Law and Medical Ethics in the Face of New Court Opinions
A. Capital Punishment and American Exceptionalism Carol Steiker, J.D.
B. Human Rights and Medical Ethics: The American Conflict Alan A. Stone, M.D.
C. Mental Disabilities and the Death Penalty: Evaluations and Legal Protections After Atkins Versus Virginia James W. Ellis, J.D.
D. Competency to Be Executed and Forced Medication: Singleton Versus Norris, Ethical Considerations Howard V. Zonana, M.D.
E. Diagnosis of Diminished Responsibility and the Death Penalty: Implications of Atkins Versus Virginia Richard Bonnie, J.D.
S17. The Scientific Basis of Expert Testimony: Its Application to Matrimonial Disputes
A. Psychiatric Testimony: Science or Wizardry? Alex Weintrob, M.D.
B. The Uses and Misuses of Psychological Tests in Child-Custody Evaluations Paul Hymowitz, Ph.D.
C. The Expectation for Evidence-Based Testimony Under Daubert Diane H. Schetky, M.D.
D. An Attorney’s Approach to Cross-Examination of an Expert in a Custody Dispute Harold A. Mayers
E. The Court’s Role Regarding Expert Testimony in Child-Custody Proceedings Anthony Marano, J.D.
S18. Evolutionary and Ethological Perspectives on Social Anxiety Disorder
A. What Social Phobia Reveals About Our Evolved Human Nature and Vice Versa Randolph M. Nesse, M.D.
B. Gene-Environment Interactions and the Development of Fearfulness in Monkeys Stephen J. Suomi, Ph.D.
C. Subordinate Status, Social Anxiety Disorder, and Dopamine Function Franklin R. Schneier, M.D.
D. Eye Contact as a Threat in Social Anxiety Disorder Justine M. Kent, M.D.
S19. Beyond B12: An Update on Nutrition and Psychiatry
A. Nutrition and Psychiatry: A Historical Perspective Kathryn M. Connor, M.D.
B. Omega-3 Essential Fatty Acids and Psychiatric Disorders Jerry M. Cott, Ph.D.
C. SAMe, Folate, and B12: One-Carbon Metabolism and Depression Jonathan E. Alpert, M.D.
D. Psychiatric Applications of Chromium Jonathan R.T. Davidson, M.D.
E. Glyconutritionals: Review and Relevance to Psychiatry Marian I. Butterfield, M.D.
S20. Telling Stories: The Psychiatrist as Novelist
A. Two Views of Human Nature: Depth Perception or Diplopia? Roderick J. Anscombe, M.D.
B. Taming Demons: The Novel as a Way of Working Through Trauma Alvin A. Rosenfeld, M.D.
C. The Novel as Grist for the Mill: Whose Psychotherapy Is It Anyway? Paul A. Buttenwieser, M.D.
D. Empathy and the Mystery Novel: Getting to the Truth Keith R. Ablow, M.D.
E. Narrative Truths: Fiction and Nonfiction Peter D. Kramer, M.D.
F. From the Laptop to the Bookstore: On Getting Your Creative Writing Published David J. Hellerstein, M.D.
S21. Do Children Benefit When Their Parents With Depression Are Treated Successfully?
A. Children at High Risk for Depression: Current Knowledge and Future Directions Myrna M. Weissman, Ph.D.
B. STAR-D Child Study: Background and Preliminary Data Daniel J. Pilowsky, M.D.
C. Good and Bad News for Low-Income Children Whose Mothers Are Treated for Depression Anne Riley, Ph.D.
D. The Effect on Children of Treating Parents for Depression Judy Garber, Ph.D.
E. Preventive Intervention for Families With Depression: Lessons From a Three-Year Follow-Up William R. Beardslee, M.D.
S22. Obesity: Lessons Learned From Addiction Collaborative Session With the National Institute on Drug Abuse
A. Genetic, Motivational, and Metabolic Factors Modulate the Neural Drive to Maintain Body Weight Barry Levin
B. Cortico-Striatal-Hypothalamic Networks and Motivation for Food: Integration of Cognition, Reward, and Energy Ann E. Kelley, Ph.D.
C. Food and Drug Cravings: Metaphor or Common Mechanism? Marcia L. Pelchat, Ph.D.
D. Common and Diverging Neurobiological Features of Feeding and Drug Self-Administration in Humans Dana Small, Ph.D.
E. Obesity and Addiction: Neuroimaging Studies Gene-Jack Wang, M.D.
S23. Alcohol, Drug, and Psychiatric Disorders in the U.S.: Current Status and Trends Collaborative Session With the National Institute on Drug Abuse
A. Prevalence, Disability, and Time Trends in Alcohol Abuse and Dependence in the U.S., 1992 to 2002 Frederick S. Stinson, Ph.D.
B. A Second Look at Binge Drinking and Alcohol Use Disorders Among College and Noncollege Youth Deborah A. Dawson, Ph.D.
C. Major Depression, Alcohol, and Drug Use Disorders in the U.S.: Variations in Co-Occurrence Deborah S. Hasin, Ph.D.
D. Trends in Prevalence of Marijuana Use Disorders in the U.S., 1992 to 2002 Wilson Compton III, M.D.
E. U.S. Prevalence of Personality Disorders and Co-Occurrence With Alcohol and Drug Use Disorders Bridget F. Grant, Ph.D.
S24. Genetic and Environmental Factors Contributing to Vulnerability to Addiction Collaborative Session With the National Institute on Drug Abuse
A. Using Twin Data to Identify Alternative Drug-Abuse Phenotypes Ming T. Tsuang, M.D.
B. Common and Specific Genetic Factors in the Development of Substance Dependence Laura J. Bierut, M.D.
C. Addiction Molecular Genetics: Remarkably Converging Results George Uhl, M.D.
D. Using the Systems Biology of Motivation for Genetic Studies in Psychiatry Gregory P. Gasic, Ph.D.
E. Genetic and Environmental Factors Modulate Cocaine Abuse in Monkey Models Michael Nader, Ph.D.
S25. Psychiatric Rehabilitation: Integrating Mind and Body Globally World Psychiatric Association’s Section on Rehabilitation and World Association for Psychosocial Rehabilitation
A. Brain Responses to the Environment: Showing Rehabilitation Works Robert Cancro, M.D.
B. Schizophrenia and Drug-Abuse Outcomes: Poverty, Culture, and Community Gregory C. Bunt, M.D.
C. Human Rights for Individuals With Mental Illnesses Humberto Martinez, M.D.
D. The Worldwide Family Movement Geraldine Marshall
E. Penetrating Prisons With Rehabilitiation Zebulon C. Taintor, M.D.
S26. Effective Treatment of PTSD: What Works Best for Whom?
A. Exposure Versus Pharmacological Treatment of PTSD: Differential Response and Long-Term Outcome Bessel A. Van Der Kolk, M.D.
B. What Works Best for Whom? Case Studies in Combination Treatment Randall D. Marshall, M.D.
C. Emotion Regulation and Interpersonal Skills Training for Chronic PTSD Related to Childhood Abuse and Multiple Traumatization Marylene Cloitre, Ph.D.
D. PTSD Treatment Outcome Research: The Study of Unrepresentative Samples Joseph F. Spinazzola, Ph.D.
IS36. BPD: Regulation of Affect and Impulse Control Supported by Bristol-Myers Squibb Company
A. New Findings on the Biology of BPD Martin Bohus, M.D.
B. BPD and Mood Disorder Sectrum Pablo Goldberg, M.D.
C. BPD and the Impulse-Control Spectrum Emil F. Coccaro, M.D.
D. Evidence-Based Psychotherapy for BPD Glen O. Gabbard, M.D.
E. Pharmacological Treatment of BPD: Current and Future Strategies Jeffrey A. Lieberman, M.D.
IS37. Interferon-Induced Depression: Consequences of Treating Chronic Hepatitis C Supported by Roche Laboratories
A. Interferon-Induced Depression: An Overview and Analysis Gregory M. Asnis, M.D.
B. Pathophysiological Mechanisms of Interferon Alpha-Induced Neuropsychiatric Symptoms Lucile Capuron, Ph.D.
C. Pegylated Interferon: Therapy of Hepatitis C With Fewer Depressive Effects John F. Reinus, M.D.
D. Diagnosis and Treatment of Interferon Alpha-Psychiatric Side Effects in Patients With Hepatitis C Virus Charles Raison, M.D.
IS38. Conceptualizing and Treating ADHD Adults Supported by Shire US Inc.
A. ADHD Adult Case Jefferson B. Prince, M.D.
B. Adult ADHD: A Conceptual Model Russell A. Barkley, Ph.D.
C. Neurobiology of Adult ADHD Francisco Castellanos, M.D.
D. Adult ADHD: A Family-Genetic Perspective Stephen V. Faraone, Ph.D.
E. Adult ADHD: What Does Neuropsychology Tell Us? Larry J. Seidman, Ph.D.
F. Pharmacologic Treatment of Adult ADHD Timothy E. Wilens, M.D.
IS39. Plotting a Course to Remission: Navigating the Intersection of Mind, Brain, and Body Supported by Eli Lilly and Company and Boehringer Ingelheim Pharmaceuticals Inc.
A. Does Everybody Hurt? Epidemiology of Physical Symptoms and Depression Maurice M. Ohayon, M.D.
B. Comorbidity With Painful Physical Symptoms: Understanding the Intersection of Brain and Body Bruce A. Arnow, Ph.D.
C. 5HT and Norepinephrine: Navigating the Broad Range of Symptoms Pedro L. Delgado, M.D.
D. Plotting the Course to Remission: Balanced Strategies to Improve Outcomes Vivien K. Burt, M.D.
E Looking Beyond the Symptoms of Depression: Considerations for Special Populations Ruta M. Nonacs, M.D.
IS40. Pharmacotherapy of Addictions: From Clinics Into Office Practice Supported by Reckitt Benckiser Pharmaceuticals
A. Prescription Drug Abuse and Psychiatric Comorbidity H. Westley Clark, M.D.
B. Opiate Pharmacotherapy and the Neurobiology of Opiate Abuse and Dependence Thomas R. Kosten, M.D.
C. Pain and Depression: Gateway to Addiction and Opportunity for Treatment Walter Ling, M.D.
D. Buprenorphine for Opiate Addiction Treatment: Pharmacology and Clinical Use Laura F. McNicholas, M.D.
E. Cultural Sensitivity in Addictions Treatment Gerado Gonzalez, M.D.
IS41. Hormones, Mood, and Cognition: Treatment Considerations in Older Women Supported by Wyeth Pharmaceuticals
A. Gonadal Steroids and the Brain: Implications in Aging Women Meir Steiner, M.D.
B. Depression in Perimenopausal Women: Women at Risk and Response to Antidepressants Lee S. Cohen, M.D.
C. Menopause and Mood Disturbances: From Theory to Novel Treatment Strategies Claudio N. Soares, M.D.
D. Assessment and Treatment of Hot Flashes in Menopausal Women Hadine Joffe, M.D.
E. The Women’s Health Institute Memory Study: Updates on the Effect of Estrogen Plus Progestin on the Incidence of Dementia and Cognitive Impairment in Menopausal Women Sally A. Shumaker, Ph.D.
IS42. Reaching Beyond Alzheimer’s Disease With Cholinergic Therapy Supported by Novartis Pharmaceuticals Corporation
A. Dementia With Lewy Bodies Within Our Grasp Ian G. McKeith, M.D.
B. Parkinson’s Disease Beyond Dopaminergic Therapy Amos Korczyn, M.D.
C. Exploring and Managing Vascular Features of Dementia Martin K. Farlow, M.D.
D. Extending Treatment Options and Not Letting Go Gustavo Alva, M.D. ▪